Share Email Print
cover

Proceedings Paper

Novel type 1 photosensitizers: viability of leukemia cells exposed to reactive intermediates generated in situ by in vitro photofragmentation
Author(s): Raghavan Rajagopalan; Amol Karwa; Przemyslaw M. Lusiak; Kripa Srivastava; Amruta R. Poreddy; Raghootama S. Pandurangi; Karen P. Galen; William L. Neumann; Gary E. Cantrell; Richard B. Dorshow
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Photodynamic therapy of tumors involving Type 2 photosenstizers has been conspicuously successful, but the Type 1 process, in contrast, has not received much attention despite its considerable potential. Accordingly, several classes of molecules containing fragile bonds such as azido (-N=N=N), azo (-N=N-), sulfenato (-S-O-) and oxaza (-N-O-) functional groups that produce reactive intermediates such as radicals and nitrenes upon photoexcitation were prepared and tested for cell viability using U397 leukemia cell line. The azido photosensitizer was conjugated to leukemia cell binding peptide, SFFWRLS, for targeted cell viability study. The cells were incubated with the photosensitizer at various concentrations, and were illuminated for 5, 10, and 20 minutes. The results show that all the photosensitizers caused cell death compared to the controls when exposed to both the photosensitizers and light. Most importantly, selective cell death was observed with the azido peptide conjugate 6, which clearly demonstrates that these Type 1 sensitizers are useful for phototherapeutic applications.

Paper Details

Date Published: 13 July 2009
PDF: 8 pages
Proc. SPIE 7380, Photodynamic Therapy: Back to the Future, 738027 (13 July 2009); doi: 10.1117/12.822840
Show Author Affiliations
Raghavan Rajagopalan, Covidien Imaging Solutions (United States)
Amol Karwa, Covidien Imaging Solutions (United States)
Przemyslaw M. Lusiak, Covidien Imaging Solutions (United States)
Kripa Srivastava, Covidien Imaging Solutions (United States)
Amruta R. Poreddy, Covidien Imaging Solutions (United States)
Raghootama S. Pandurangi, Covidien Imaging Solutions (United States)
Karen P. Galen, Covidien Imaging Solutions (United States)
William L. Neumann, Southern Illinois Univ. (United States)
Gary E. Cantrell, Covidien Imaging Solutions (United States)
Richard B. Dorshow, Covidien Imaging Solutions (United States)


Published in SPIE Proceedings Vol. 7380:
Photodynamic Therapy: Back to the Future
David H. Kessel, Editor(s)

© SPIE. Terms of Use
Back to Top